Researchers developed monoclonal antibodies from primitive neuroectodermal tumors. These antibodies identify neuroectodermal tumor markers, confirming the tumor
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: